Design and Development of Novel Responsive Carrier for Drug Delivery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 7571
Special Issue Editor
Special Issue Information
Dear Colleagues,
Advanced drug delivery technology has been widely explored for the precise treatment of diseases. The pathological structures and signals of the diseased sites are the generally used targets of drug delivery systems. Precisely matching the responsiveness of the carrier to the pathological signal is a prerequisite for the design of an ideal drug delivery system. Therefore, pathological signal discovery and the design of responsive carriers are both critical for obtaining proper formulations. This issue will focus on the pathological signals and the associated newly developed disease-targeting carriers.
In this light, pathological signals including ROS, acidic environment, inflammation signals, cell types, enzymes, and antigens represent the widely used stimuli for the design of the disease-targeting formulations. Drug carriers including liposomes, polymeric micelles, polymers, antibodies, cell-based carriers, cell-membrane particles, exosomes, microneedle array patch, and inorganic nanoparticles all represent efficient carriers to selectively deliver drugs, including small chemical molecules, proteins, DNA, and RNA, to the targeting diseased sites. As such, this Special Issue welcomes submissions from researchers in the field of medical science and drug delivery, including original research and review articles related to pharmaceutic science, material science, life science, medical science, and biomedical engineering.
Prof. Dr. Jinqiang Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Biomaterials
- Nanotechnology
- Theragnostic
- Disease targeting
- Drug delivery Stimuli-responsive
- Nanoparticles
- Signal-responsive
- Responsive carriers
- Pathological signal
- Drug conjugates
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.